2022 Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics Sales Report
March 30, 2023 12:18 ET
|
Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics" report has been added to ResearchAndMarkets.com's...
U.S. Biopharmaceutical CMO & CRO Market Report 2023: Need for Flexible and Scalable Manufacturing Solutions Fuels Growth
March 13, 2023 07:03 ET
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "U.S. Biopharmaceutical CMO & CRO Market Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Service (Contract...
State of the Biopharmaceutical Industry 2023: Emerging Technologies, Industry Trends, Regulatory Trends, and Microeconomic Factors
March 09, 2023 11:38 ET
|
Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2023" report has been added to ResearchAndMarkets.com's offering.This report examines the business...
Global Biologics Safety Testing Market Report 2023: Growing Development of Biosimilars and Biologics Bolsters Growth
February 22, 2023 10:58 ET
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The " Global Biologics Safety Testing Market by Product & Service (Instruments, Consumables, Services), Application (mAbs, Vaccine, Cell & Gene...
The Worldwide Biosimilars Industry is Expected to Reach $47.4 Billion by 2027: Patent Expiration of Well-Known Biologics Drives Growth
February 10, 2023 11:03 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market Size, Trends and Growth Opportunity, By Product, By Indication, By Region and Forecast to 2027." report has been added to ...
Biosimilar Contract Manufacturing Global Market Report 2022: Favorable Policies Encouraging Use of Biosimilars Present Opportunities
January 12, 2023 07:23 ET
|
Research and Markets
Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "Biosimilar Contract Manufacturing Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.The...
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2023: Increasing Healthcare Access Bolsters Sector
January 11, 2023 04:48 ET
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ...
Insights on the Oncology Biosimilars Global Market to 2027: Rising Number of Geriatric Population and Environmental Degradation Drives Growth
January 03, 2023 05:28 ET
|
Research and Markets
Dublin, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Oncology Biosimilars Global Market Report 2022: Increasing Approvals in North America to Set the Stage for Swift Growth
December 09, 2022 05:58 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Biosimilar Therapeutic Peptides Global Market Report 2022: Research Collaborations Present Lucrative Opportunities for Growth
November 24, 2022 06:53 ET
|
Research and Markets
Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Therapeutic Peptides Global Market Report 2022: By Route, By Application, By Type" report has been added to ResearchAndMarkets.com's...